Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

Clinical trial NCT00335335 · TERMINATED

Trial details

NCT number: NCT00335335
Sponsor: GE Healthcare
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2006-05-01
Primary completion: 2006-12-02
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.